The EA-Technology portfolio utilizes 3 point of care autologous preparation systems that provide new advanced solutions for the creation of safer, more cost-effective biological solutions over existing industry standards.
The Maxx-Cell® system maximizes the yield of stem and progenitor cells by giving the clinician the ability to efficiently harvest bone marrow from multiple levels within the medullary space, while restricting dilution of peripheral blood.
Reduce the cost of utilizing high priced biologics. Maxx-Cell® delivers better regenerative solutions at reduced cost compared to industry leading solutions. Create the highest live cellular product, point of care in any clinical setting.
Centrifugation systems typically require 20 minutes or more of spin time during the surgical procedure, not to mention the additional support time needed for preparation and cleanup of equipment. No centrifuge needed.
Centrifugation systems require passing the BMA off the sterile field for processing and back on for implantation. Maxx™-Cell eliminates the additional steps where infection concerns must be managed.
Centrifugation systems typically discard 80% of the aspirate due to the high levels of peripheral blood. Worse, significant numbers of the desired cells (approx. 40%) are discarded because as these cells increase in density prior to division, they are processed into the undesired red cell centrifuge component and thus discarded, substantially limiting regenerative potential of the resulting sample.
CUSTOMIZABLE PRP AT YOUR FINGERTIPS TO TREAT A VARIETY OF CONDITIONS.
Maxx™ PRP provides a 4-6x level over baseline concentration of platelets, promoting the following growth factors:
VEGF – Vascular Endothelial Growth Factors
PDGF – Platelet Derived Growth Factors
TGF – Transforming Growth Factors
MAXX™ – BMC delivers world class results with an ability to capture platelet yields over 70%+ and customizable hematocrit settings.
MAXX™-BMC’S patented lead screw technology allows users to customize their final product by providing detailed platelet, buffy coat and hematocrit options, all at the users fingertips.
MAXX™- BMC offers 2 streamlined concentration time cycles, allowing users to select from one or two spin cycles for superior and ultra concentration settings.
Ability to process bone marrow aspirate and whole blood at the point of care. A single kit can process 30-60ml of bone marrow/and or blood to produce a user defined custom end product. Average output is 7-10ml’s
MAXX™-BMC harnesses the bodies essential growth factors for accelerated concentrations over baseline.
MAXX™-BMC concentration system is designed to be used at the patient’s point of care for the safe and rapid preparation of a platelet rich plasma (PRP) from a small sample of a mixture of peripheral blood and bone marrow aspirate that is mixed with autograft and or allograft bone prior to application to a bony defect for improving handling characteristics.
